Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular Diagnostics (PCR)), Animal (Companion, Food-producing animals), End User (Reference Labs, Hospital, Clinics, Universities) - Global Forecast to 2026
The veterinary infectious disease diagnostics market is expected to reach USD 2.6 billion by 2026 from an estimated USD 1.7 billion in 2021, at a CAGR of 9.0%. The major factors driving the growth of the veterinary infectious disease diagnostics include the growing demand for rapid tests, rising technological advancements, growth in companion animal population, rising demand for pet insurance, increasing incidence of transboundary and zoonotic diseases, rising number of veterinary practitioners in developed economies, increasing disease control & disease prevention measures, and growing animal health expenditure. With the growing consumption of animal-derived food products, there is a rising need for the effective diagnosis and treatment of diseases in animals to ensure the quality of animal-derived food products. The rising need for animal-derived food products will further increase the chances for infections, thereby driving the growth of this market in the coming years. However, high pet care costs directly impact the number of visits by pet owners to veterinary facilities, thereby restraining the growth of this market and the lack of reimbursement for veterinary procedures is another factor limiting the uptake of veterinary infectious disease diagnostics. The lack of skilled veterinarians and diagnostics infrastructure, especially in developing countries, is one of the major challenges limiting the uptake of advanced diagnostic solutions among veterinarians.
Since the initial outbreak of COVID-19, multiple countries have reported infections of SARS-CoV-2 in mammals. Due to an increase in the prevalence of COVID-19 across the globe, testing volumes on humans and animals continue to rise. This has also prompted players and reference laboratories to develop new and improved animal tests. At the height of the pandemic, many countries stipulated that only urgent or emergency procedures necessary for the veterinary healthcare of companion animals could take place. However, COVID-19 pandemic is expected to have a minimal impact on the veterinary infectious disease diagnostics market during the forecast period as after few months, number of vet visits were increased and there was no delay in routine care.
Immunodiagnostics segment occupies the largest share in the global veterinary infectious disease diagnostics market in the forecasted period
Based on technology, the global veterinary infectious disease diagnostics market is segmented into Immunodiagnostics, Molecular Diagnostics, and Other Technologies. The higher preference for this technology by veterinarians, pet owners, and livestock producers contributes to the large share of the immunodiagnostics segment. The growing demand for early & accurate diagnosis; increasing preference for in-house testing; and the increasing applications of immunodiagnostics are supporting the growth of this application segment.
The companion animal segment dominated the global veterinary infectious disease diagnostics market in 2020
Based on the animal type, the global veterinary infectious disease diagnostics market is segmented into companion animal and food-producing animals. In 2020, the companion animals segment accounted for the largest share of the global veterinary infectious disease diagnostics market. The growth in this segment is attributed to the increasing pet ownership (especially in developed countries), rising penetration of pet insurance, a growing number of veterinary practitioners globally, and increasing animal disease control and disease prevention measures.
Veterinary reference laboratories are the major end users in the veterinary infectious disease diagnostics market
Based on end users, the global veterinary infectious disease diagnostics market is segmented into veterinary reference laboratories, veterinary hospitals and clinics, point-of-care testing/in-house testing, and veterinary research institutes and universities. In 2020, veterinary reference laboratories were the major end users in the veterinary infectious disease diagnostics market. The large share of this segment can primarily be attributed to the growing number of veterinarians, the increasing number of veterinary practices, and the rising number of samples received for diagnostics in reference laboratories from small and large animal practices. Rising awareness among pet owners regarding routine and preventive care is further expected to propel market growth.
North America accounts for the largest share in the global veterinary infectious disease diagnostics market in the forecasted period
North America accounted for the largest share of the global veterinary infectious disease diagnostics market during the forecast period. The growth in the veterinary infectious disease diagnostics market of North America is characterized by the increasing population of companion and food-producing animals, rising meat and dairy product consumption, the availability of technologically advanced veterinary reference laboratories, rising veterinary healthcare expenditure, and growth in pet insurance coverage.
The break of primary participants was as mentioned below:
The key players in the veterinary diagnostics market include IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), bioM?rieux SA (France), Heska Corporation (US), IDvet (France), NEOGEN Corporation (US), QIAGEN N.V. (a part of INDICAL Bioscience) (Europe), Randox Laboratories Ltd. (UK), Agrolabo S.p.A. (Italy), Bio-Rad Laboratories (US), Bionote, Inc. (South Korea), Biogal Galed Labs (Israel), BioChek (Netherlands), (UK), Biopanda Reagents (UK), URIT Medical Electronic Co. Ltd. (China), MEGACOR Diagnostik GmbH (Austria), LIVET (UK), INDICAL BIOSCIENCE GmbH (Germany), Fassisi GmbH (Germany), Alvedia (France), SKYER, Inc. (South Korea), Shenzhen Bioeasy Biotechnology Co., Ltd. (China), and Precision Biosensor (US).
Research Coverage:
The report analyzes the veterinary infectious disease diagnostics market and aims at estimating the market size and future growth potential of this market based on various segments such as technology, animal type, end user, and region. The report also includes a product portfolio matrix of various veterinary infectious disease diagnostics products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
Since the initial outbreak of COVID-19, multiple countries have reported infections of SARS-CoV-2 in mammals. Due to an increase in the prevalence of COVID-19 across the globe, testing volumes on humans and animals continue to rise. This has also prompted players and reference laboratories to develop new and improved animal tests. At the height of the pandemic, many countries stipulated that only urgent or emergency procedures necessary for the veterinary healthcare of companion animals could take place. However, COVID-19 pandemic is expected to have a minimal impact on the veterinary infectious disease diagnostics market during the forecast period as after few months, number of vet visits were increased and there was no delay in routine care.
Immunodiagnostics segment occupies the largest share in the global veterinary infectious disease diagnostics market in the forecasted period
Based on technology, the global veterinary infectious disease diagnostics market is segmented into Immunodiagnostics, Molecular Diagnostics, and Other Technologies. The higher preference for this technology by veterinarians, pet owners, and livestock producers contributes to the large share of the immunodiagnostics segment. The growing demand for early & accurate diagnosis; increasing preference for in-house testing; and the increasing applications of immunodiagnostics are supporting the growth of this application segment.
The companion animal segment dominated the global veterinary infectious disease diagnostics market in 2020
Based on the animal type, the global veterinary infectious disease diagnostics market is segmented into companion animal and food-producing animals. In 2020, the companion animals segment accounted for the largest share of the global veterinary infectious disease diagnostics market. The growth in this segment is attributed to the increasing pet ownership (especially in developed countries), rising penetration of pet insurance, a growing number of veterinary practitioners globally, and increasing animal disease control and disease prevention measures.
Veterinary reference laboratories are the major end users in the veterinary infectious disease diagnostics market
Based on end users, the global veterinary infectious disease diagnostics market is segmented into veterinary reference laboratories, veterinary hospitals and clinics, point-of-care testing/in-house testing, and veterinary research institutes and universities. In 2020, veterinary reference laboratories were the major end users in the veterinary infectious disease diagnostics market. The large share of this segment can primarily be attributed to the growing number of veterinarians, the increasing number of veterinary practices, and the rising number of samples received for diagnostics in reference laboratories from small and large animal practices. Rising awareness among pet owners regarding routine and preventive care is further expected to propel market growth.
North America accounts for the largest share in the global veterinary infectious disease diagnostics market in the forecasted period
North America accounted for the largest share of the global veterinary infectious disease diagnostics market during the forecast period. The growth in the veterinary infectious disease diagnostics market of North America is characterized by the increasing population of companion and food-producing animals, rising meat and dairy product consumption, the availability of technologically advanced veterinary reference laboratories, rising veterinary healthcare expenditure, and growth in pet insurance coverage.
The break of primary participants was as mentioned below:
- By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10%
- By Designation – C-level–30%, Director-level–50%, Others–20%
- By Region – North America–45%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East and Africa–5%
The key players in the veterinary diagnostics market include IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), bioM?rieux SA (France), Heska Corporation (US), IDvet (France), NEOGEN Corporation (US), QIAGEN N.V. (a part of INDICAL Bioscience) (Europe), Randox Laboratories Ltd. (UK), Agrolabo S.p.A. (Italy), Bio-Rad Laboratories (US), Bionote, Inc. (South Korea), Biogal Galed Labs (Israel), BioChek (Netherlands), (UK), Biopanda Reagents (UK), URIT Medical Electronic Co. Ltd. (China), MEGACOR Diagnostik GmbH (Austria), LIVET (UK), INDICAL BIOSCIENCE GmbH (Germany), Fassisi GmbH (Germany), Alvedia (France), SKYER, Inc. (South Korea), Shenzhen Bioeasy Biotechnology Co., Ltd. (China), and Precision Biosensor (US).
Research Coverage:
The report analyzes the veterinary infectious disease diagnostics market and aims at estimating the market size and future growth potential of this market based on various segments such as technology, animal type, end user, and region. The report also includes a product portfolio matrix of various veterinary infectious disease diagnostics products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global veterinary infectious disease diagnostics market. The report analyzes this market by technology, animal type, and end user.
- Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global veterinary infectious disease diagnostics market.
- Market Development: Comprehensive information on the lucrative emerging markets by technology, animal type, and end user.
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global veterinary infectious disease diagnostics market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global veterinary infectious disease diagnostics market.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKET SEGMENTATION
FIGURE 1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
2.1.2.3 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 9 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: COMPANION DIAGNOSTICS MARKET (2020)
FIGURE 10 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: FOOD-PRODUCING ANIMALS DIAGNOSTICS MARKET (2020)
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2021–2026)
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: VETERINARY INFECTIOUS DISEASE
DIAGNOSTICS MARKET
3 EXECUTIVE SUMMARY
FIGURE 15 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
FIGURE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 17 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
4 PREMIUM INSIGHTS
4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
FIGURE 19 GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE
THE MARKET GROWTH
4.2 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER AND COUNTRY (2020)
FIGURE 20 THE VETERINARY REFERENCE LABORATORIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
4.3 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE GLOBAL MARKET DURING THE FORECAST PERIOD
4.4 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION (2019–2026)
FIGURE 22 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.5 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 23 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Rising demand for animal-derived food products
TABLE 3 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT & MILK IN DEVELOPED AND DEVELOPING COUNTRIES
TABLE 4 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 25 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN 2018
5.2.1.2 Increasing companion animal population
5.2.1.3 Rising demand for pet insurance and the subsequent growth in animal health expenditure
TABLE 5 AVERAGE PREMIUMS PAID IN THE US, 2019 VS. 2020
FIGURE 26 US: PET INDUSTRY EXPENDITURE, 2010–2019
5.2.1.4 Growing number of veterinary practitioners in developed economies
TABLE 6 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018
5.2.1.5 Increasing disease control & disease prevention measures
5.2.1.6 Rising incidence of transboundary & zoonotic diseases
TABLE 7 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019)
5.2.1.7 Growing demand for advanced diagnostic devices
5.2.2 MARKET RESTRAINTS
5.2.2.1 Rising pet care costs
5.2.2.2 High costs of veterinary diagnostic tests
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Increasing use of PCR-testing panels for COVID-19 testing in animals
5.2.3.2 Untapped emerging economies
5.2.4 MARKET CHALLENGES
5.2.4.1 Shortage of veterinary practitioners in developing markets
5.2.4.2 Lack of animal healthcare awareness in emerging countries
TABLE 8 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018
5.3 IMPACT OF COVID-19 ON THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
TABLE 9 GLOBAL SNAPSHOT OF THE REPORTED CASES OF NATURALLY ACQUIRED SARS- COV-2 (COVID-19) INFECTIONS IN ANIMALS
FIGURE 27 MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION, JANUARY–JUNE 2020
5.4 INDUSTRY TRENDS
5.4.1 RISING VEGAN POPULATION
5.4.2 ADOPTION OF WEB MONITORING AND OTHER DIGITAL AIDS TO DETECT EMERGING INFECTIOUS DISEASES IN ANIMALS
5.4.3 EXPANSIVE GROWTH IN VETERINARY BUSINESSES
5.5 VALUE CHAIN ANALYSIS
FIGURE 28 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM MARKET MAP
FIGURE 29 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS
FIGURE 30 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:
ECOSYSTEM MARKET
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 PRICING ANALYSIS
TABLE 11 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2021 (USD)
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS
5.9.2 PATENT PUBLICATION TRENDS (2011–DECEMBER 2021)
5.9.3 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PATENTS (JANUARY
2011–DECEMBER 2021)
FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2011–DECEMBER 2021)
5.10 TECHNOLOGICAL ANALYSIS
5.10.1 KEY TECHNOLOGY
5.10.1.1 Development of portable instruments for POC diagnostic services
TABLE 12 PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS
5.10.2 ADJACENT TECHNOLOGY
5.10.2.1 Development of rapid and sensitive veterinary diagnostic kits
6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
TABLE 13 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
6.2 IMMUNODIAGNOSTICS
TABLE 14 KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN THE MARKET
TABLE 15 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1 LATERAL FLOW ASSAYS
6.2.1.1 Lateral flow assays offer rapid results & accurate diagnosis
TABLE 17 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2 ELISA TESTS
6.2.2.1 ELISA tests have gained widespread popularity in the market owing to their efficacy and accurate validation of results
TABLE 18 ELISA TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3 OTHER IMMUNODIAGNOSTIC PRODUCTS
TABLE 19 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3 MOLECULAR DIAGNOSTICS
TABLE 20 KEY VETERINARY MOLECULAR DIAGNOSTICS PRODUCTS
AVAILABLE IN THE MARKET
TABLE 21 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.1 POLYMERASE CHAIN REACTION (PCR) TESTS
6.3.1.1 PCR is an effective tool for the diagnosis of diseases in food-producing animals and companion animals
TABLE 23 PCR TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.2 MICROARRAYS
6.3.2.1 Technological advancements and the increasing incidence of infectious diseases are factors supporting the growth of this market
TABLE 24 MICROARRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
TABLE 25 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.4 OTHER TECHNOLOGIES
TABLE 26 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION)
7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE
7.1 INTRODUCTION
TABLE 27 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
7.2 COMPANION ANIMALS
TABLE 28 POPULATION OF COMPANION ANIMALS, BY COUNTRY, 2012–2019 (MILLION)
TABLE 29 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 30 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1 DOGS
7.2.1.1 The pet dog population has grown significantly in recent years
TABLE 31 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING DOGS
TABLE 32 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING DOGS
TABLE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 CATS
7.2.2.1 Increasing pet cat population to drive the market growth
TABLE 34 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATS
TABLE 35 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATS
TABLE 36 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 HORSES
7.2.3.1 Research programs on horse health awareness is a major factor driving the demand for infection diagnostics for this segment
TABLE 37 HORSE POPULATION, BY REGION, 2014–2017 (USD MILLION)
TABLE 38 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING HORSES
TABLE 39 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING HORSES
TABLE 40 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 OTHER COMPANION ANIMALS
TABLE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE
TABLE 42 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
7.2.5.1 Viral infections
7.2.5.1.1 The highly contagious nature of viral diseases is a major factor driving the demand for infection diagnostics in companion animals
TABLE 43 PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN COMPANION ANIMALS
TABLE 44 VIRAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.2.5.2 Bacterial infections
7.2.5.2.1 The bacterial infections segment accounted for the largest share of the market in 2020
TABLE 45 PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN COMPANION ANIMALS
TABLE 46 BACTERIAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.2.5.3 Parasitic infections
7.2.5.3.1 Rising incidence of worm infestation in companion animals to support the growth of this market
TABLE 47 PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS IN COMPANION ANIMALS
TABLE 48 PARASITIC DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.2.5.4 Other infections
TABLE 49 PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN COMPANION ANIMALS
TABLE 50 PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS IN COMPANION ANIMALS
TABLE 51 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3 FOOD-PRODUCING ANIMALS
7.3.1 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE
TABLE 52 POPULATION OF FOOD-PRODUCING ANIMALS IN THE US, 2012 TO 2019 (MILLION)
TABLE 53 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 54 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.1 Cattle
7.3.1.1.1 Growing demand for meat & dairy products to support the growth of this segment
TABLE 55 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATTLE
TABLE 56 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATTLE
TABLE 57 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.2 Swine
7.3.1.2.1 Extensive use of infectious disease diagnostics as a response to epidemic outbreaks in this segment
TABLE 58 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING SWINE
TABLE 59 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING SWINE
TABLE 60 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR SWINE, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.3 Poultry
7.3.1.3.1 The growth of this segment is driven by the growing poultry population and rising production volumes
TABLE 61 SOME OF THE IMPORTANT ZOONOTIC DISEASES AFFECTING POULTRY
TABLE 62 SOME IMPORTANT INFECTIOUS DISEASES AFFECTING POULTRY
TABLE 63 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.4 Other food-producing animals
TABLE 64 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING OTHER FOOD -PRODUCING ANIMALS
TABLE 65 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE
TABLE 66 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
7.3.2.1 Bacterial infections
7.3.2.1.1 The bacterial infections segment accounted for the largest share of the food-producing animals market in 2020
TABLE 67 PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN FOOD-PRODUCING ANIMALS
TABLE 68 BACTERIAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3.2.2 Viral infections
7.3.2.2.1 Need for early disease diagnosis and the rising awareness for viral infections to support the market growth
TABLE 69 PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN FOOD-PRODUCING ANIMALS
TABLE 70 VIRAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3.2.3 Parasitic infections
7.3.2.3.1 Worm infestations are a significant problem for pet & companion animal owners
TABLE 71 PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS
IN FOOD-PRODUCING ANIMALS
TABLE 72 PARASITIC DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3.2.4 Other infections
TABLE 73 PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN FOOD-PRODUCING ANIMALS
TABLE 74 PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS
IN FOOD- PRODUCING ANIMALS
TABLE 75 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
8 VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER
8.1 INTRODUCTION
TABLE 76 VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 VETERINARY REFERENCE LABORATORIES
8.2.1 VETERINARY REFERENCE LABORATORIES IS THE LARGEST
END USER SEGMENT
TABLE 77 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 VETERINARY HOSPITALS & CLINICS
8.3.1 INCREASED PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET GROWTH
FIGURE 33 US: PET INDUSTRY EXPENDITURE
FIGURE 34 ANNUAL ROUTINE VETERINARY VISIT EXPENDITURE: DOGS AND CATS
TABLE 78 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 POINT-OF-CARE/ IN-HOUSE TESTING
8.4.1 POINT-OF-CARE TESTING IS EASY-TO-USE, COST-EFFECTIVE, AND OFFERS SWIFT RESULTS
TABLE 79 KEY PRODUCTS OFFERED BY MARKET PLAYERS
TABLE 80 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POINT-OF-CARE/ IN-HOUSE TESTING, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
8.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES & UNIVERSITIES TO DRIVE MARKET GROWTH
TABLE 81 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2019–2026 (USD MILLION)
9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 82 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 35 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA
FIGURE 36 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
TABLE 83 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 84 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 85 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 86 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 87 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 88 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 90 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 92 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominated the North American veterinary infectious disease diagnostics market in 2020
FIGURE 37 US: DOGS POPULATION, 2012–2020 (MILLION)
FIGURE 38 US: EXPENDITURE ON VET VISITS
TABLE 93 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION)
FIGURE 39 US: NUMBER OF CATS AND DOGS TESTED POSITIVE FOR COVID-19 (2020)
TABLE 94 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014–2019
TABLE 95 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 96 US: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 97 US: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 98 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 99 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 101 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 103 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing pet adoption in Canada to drive the market growth
FIGURE 40 CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION)
TABLE 104 CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
TABLE 105 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 106 CANADA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 107 CANADA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 108 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 109 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 111 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 113 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 114 EUROPE: COMPANION POPULATION, 2019 (MILLION)
TABLE 115 EUROPE: LIVESTOCK POPULATION, 2019 (MILLION)
FIGURE 41 EU-27: LIVESTOCK POPULATION, 2012-2019 (MILLION)
TABLE 116 EUROPE: NUMBER OF VETERINARIANS, 2012–2019
TABLE 117 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 118 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 119 EUROPE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 120 EUROPE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 121 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 122 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 124 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 126 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Rising awareness regarding zoonotic diseases to drive the market growth in Germany
TABLE 127 GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 128 GERMANY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 129 GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019
TABLE 130 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 131 GERMANY: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 132 GERMANY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 133 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 134 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 136 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 138 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 The UK is the fastest-growing market for veterinary infectious disease diagnostics in Europe
TABLE 139 UK: COMPANION ANIMAL POPULATION (2010–2019) (MILLION)
TABLE 140 UK: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 141 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 142 UK: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 143 UK: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 144 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 145 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 146 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 147 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 149 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 France is one of the leading markets for companion pet ownership
TABLE 150 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION)
TABLE 151 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 152 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 153 FRANCE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 154 FRANCE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 155 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 156 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 157 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 158 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 159 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 160 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Rising awareness about pet healthcare to propel the market growth for veterinary diagnostic products in Italy
TABLE 161 ITALY: COMPANION ANIMAL POPULATION, 2012–2019 (MILLION)
TABLE 162 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 163 ITALY: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 164 ITALY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 165 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 166 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 167 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 168 ITALY: VETERINARY DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 170 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing demand for pig & poultry products to support the adoption of veterinary diagnostic products in Spain
TABLE 171 SPAIN: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 172 SPAIN: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 173 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 174 SPAIN: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 175 SPAIN: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 176 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 177 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 178 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 179 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 180 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 181 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 182 ROE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2019 (MILLION)
TABLE 183 ROE: LIVESTOCK ANIMAL POPULATION, BY COUNTRY, 2019 (MILLION)
TABLE 184 ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2019
TABLE 185 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 186 ROE: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 187 ROE: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 188 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 189 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 190 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 191 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 192 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 193 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 42 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
TABLE 194 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 195 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 196 ASIA PACIFIC: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 197 ASIA PACIFIC: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 198 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 199 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 200 ASIA PACIFIC: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 201 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 202 ASIA PACIFIC: FOOD-PRODUCING ANIMALS ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 203 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China dominated the APAC veterinary infectious disease diagnostic market in 2020
TABLE 204 CHINA: LIVESTOCK POPULATION, 2010-2019 (MILLION)
TABLE 205 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 206 CHINA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 207 CHINA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 208 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 209 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 210 CHINA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 211 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 212 CHINA: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 213 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising awareness about zoonotic diseases and increasing pet expenditure to drive market growth
TABLE 214 JAPAN: PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 215 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 216 JAPAN: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 217 JAPAN: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 218 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 219 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 220 JAPAN: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 221 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 222 JAPAN: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 223 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 India to become an untapped market with huge growth potential
TABLE 224 INDIA: LIVESTOCK POPULATION, 2007-2019 (MILLION)
TABLE 225 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 226 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 227 INDIA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 228 INDIA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 229 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 230 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 231 INDIA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 232 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 233 INDIA: FOOD- PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 234 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 REST OF APAC
TABLE 235 REST OF APAC: LIVESTOCK POPULATION, BY COUNTRY, 2010-2019 (MILLION)
TABLE 236 ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 237 ROAPAC: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 238 ROAPAC: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 239 ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 240 ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 241 ROAPAC: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 242 ROPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 243 ROPAC: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 244 ROPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 245 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY, 2010-2019 (MILLION)
TABLE 246 LATIN AMERICA: NUMBER OF VETERINARIANS AND PARA VETERINARIANS, 2010 VS. 2019
TABLE 247 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 248 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 249 LATIN AMERICA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 250 LATIN AMERICA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 251 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 252 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 253 LATIN AMERICA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 254 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 255 LATIN AMERICA: FOOD-PRODUICNG ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 256 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil has the fourth-largest pet population in the world
TABLE 257 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 258 BRAZIL: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 259 BRAZIL: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 260 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 261 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 262 BRAZIL: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 263 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 264 BRAZIL: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 265 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Mexico is the second-largest pet care market in Latin America
TABLE 266 MEXICO: INCREASE IN LIVESTOCK POPULATION, 2010–2019 (MILLION)
TABLE 267 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 268 MEXICO: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 269 MEXICO: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 270 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 271 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 272 MEXICO: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 273 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 274 MEXICO: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 275 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 276 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 277 ROLA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 278 ROLA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 279 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 280 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 281 ROLA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 282 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 283 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 284 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 MIDDLE EAST & AFRICA IS AN EMERGING MARKET FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PRODUCTS
TABLE 285 MIDDLE EAST: LIVESTOCK POPULATION, 2010 VS. 2019 (MILLION)
TABLE 286 MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2018
TABLE 287 AFRICA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION)
TABLE 288 AFRICA: NUMBER OF VETERINARIANS AND PARA VETERINARIANS, 2010–2018
TABLE 289 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 290 MEA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 291 MEA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 292 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 293 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 294 MEA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 295 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 296 MEA: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 297 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/ RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 43 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2020
TABLE 298 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEGREE
OF COMPETITION
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 45 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2020)
10.7 COMPANY FOOTPRINT
TABLE 299 COMPANY FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
10.7.1 TECHNOLOGY FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
TABLE 300 TECHNOLOGY FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)
10.7.2 ANIMAL FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
TABLE 301 ANIMAL TYPE FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)
10.7.3 END-USER FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
TABLE 302 END-USER FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)
10.7.4 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
TABLE 303 GEOGRAPHIC FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 304 PRODUCT LAUNCHES, 2018–2021
10.8.2 DEALS
TABLE 305 DEALS, 2018–2021
10.8.3 OTHER DEVELOPMENTS
TABLE 306 OTHER DEVELOPMENTS, 2018–2021
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 IDEXX LABORATORIES, INC.
TABLE 307 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 47 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.2 ZEOTIS
TABLE 308 ZOETIS: BUSINESS OVERVIEW
FIGURE 48 ZOETIS: COMPANY SNAPSHOT (2020)
11.1.3 THERMO FISHER SCIENTIFIC INC.
TABLE 309 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
11.1.4 VIRBAC
TABLE 310 VIRBAC: BUSINESS OVERVIEW
FIGURE 50 VIRBAC: COMPANY SNAPSHOT (2020)
11.1.5 BIOMERIEUX S.A.
TABLE 311 BIOMERIEUX S.A.: BUSINESS OVERVIEW
FIGURE 51 BIOMERIEUX S.A.: COMPANY SNAPSHOT (2020)
11.1.6 HESKA CORPORATION
TABLE 312 HESKA CORPORATION: BUSINESS OVERVIEW
FIGURE 52 HESKA CORPORATION: COMPANY SNAPSHOT (2020)
11.1.7 IDVET
TABLE 313 IDVET: BUSINESS OVERVIEW
11.1.8 NEOGEN CORPORATION
TABLE 314 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 53 NEOGEN CORPORATION: COMPANY SNAPSHOT (2020)
11.1.9 QIAGEN N.V. (A PART OF INDICAL BIOSCIENCE)
TABLE 315 QIAGEN N.V.: BUSINESS OVERVIEW
FIGURE 54 QIAGEN N.V.: COMPANY SNAPSHOT (2020)
11.1.10 RANDOX LABORATORIES LTD.
TABLE 316 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
11.1.11 AGROLABO S.P.A.
TABLE 317 AGROLABO S.P.A.: BUSINESS OVERVIEW
11.1.12 BIONOTE USA INC.
TABLE 318 BIONOTE USA INC.: BUSINESS OVERVIEW
11.1.13 BIOGAL GALED LABS
TABLE 319 BIOGAL GALED LABS: BUSINESS OVERVIEW
11.1.14 BIOCHEK
TABLE 320 BIOCHEK: BUSINESS OVERVIEW
11.1.15 BIOPANDA REAGENTS LTD.
TABLE 321 BIOPANDA REAGENTS LTD.: BUSINESS OVERVIEW
11.1.16 URIT MEDICAL ELECTRONIC CO., LTD.
TABLE 322 URIT MEDICAL ELECTRONIC CO., LTD.: BUSINESS OVERVIEW
11.1.17 MEGACOR DIAGNOSTIK GMBH
TABLE 323 MEGACOR DIAGNOSTIK GMBH: BUSINESS OVERVIEW
11.1.18 BIO-RAD LABORATORIES, INC.
TABLE 324 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
FIGURE 55 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.19 LIVET
TABLE 325 LIVET: BUSINESS OVERVIEW
11.1.20 INDICAL BIOSCIENCE GMBH
TABLE 326 INDICAL BIOSCIENCE GMBH: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 FASSISI, GMBH
11.2.2 ALVEDIA
11.2.3 SKYER, INC.
11.2.4 SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.
11.2.5 PRECISION BIOSENSOR
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKET SEGMENTATION
FIGURE 1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
2.1.2.3 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 9 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: COMPANION DIAGNOSTICS MARKET (2020)
FIGURE 10 SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: FOOD-PRODUCING ANIMALS DIAGNOSTICS MARKET (2020)
FIGURE 11 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2021–2026)
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 13 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: VETERINARY INFECTIOUS DISEASE
DIAGNOSTICS MARKET
3 EXECUTIVE SUMMARY
FIGURE 15 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
FIGURE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 17 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
4 PREMIUM INSIGHTS
4.1 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
FIGURE 19 GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE
THE MARKET GROWTH
4.2 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER AND COUNTRY (2020)
FIGURE 20 THE VETERINARY REFERENCE LABORATORIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
4.3 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE GLOBAL MARKET DURING THE FORECAST PERIOD
4.4 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION (2019–2026)
FIGURE 22 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
4.5 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 23 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 24 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Rising demand for animal-derived food products
TABLE 3 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT & MILK IN DEVELOPED AND DEVELOPING COUNTRIES
TABLE 4 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
FIGURE 25 ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN 2018
5.2.1.2 Increasing companion animal population
5.2.1.3 Rising demand for pet insurance and the subsequent growth in animal health expenditure
TABLE 5 AVERAGE PREMIUMS PAID IN THE US, 2019 VS. 2020
FIGURE 26 US: PET INDUSTRY EXPENDITURE, 2010–2019
5.2.1.4 Growing number of veterinary practitioners in developed economies
TABLE 6 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018
5.2.1.5 Increasing disease control & disease prevention measures
5.2.1.6 Rising incidence of transboundary & zoonotic diseases
TABLE 7 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019)
5.2.1.7 Growing demand for advanced diagnostic devices
5.2.2 MARKET RESTRAINTS
5.2.2.1 Rising pet care costs
5.2.2.2 High costs of veterinary diagnostic tests
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Increasing use of PCR-testing panels for COVID-19 testing in animals
5.2.3.2 Untapped emerging economies
5.2.4 MARKET CHALLENGES
5.2.4.1 Shortage of veterinary practitioners in developing markets
5.2.4.2 Lack of animal healthcare awareness in emerging countries
TABLE 8 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018
5.3 IMPACT OF COVID-19 ON THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
TABLE 9 GLOBAL SNAPSHOT OF THE REPORTED CASES OF NATURALLY ACQUIRED SARS- COV-2 (COVID-19) INFECTIONS IN ANIMALS
FIGURE 27 MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION, JANUARY–JUNE 2020
5.4 INDUSTRY TRENDS
5.4.1 RISING VEGAN POPULATION
5.4.2 ADOPTION OF WEB MONITORING AND OTHER DIGITAL AIDS TO DETECT EMERGING INFECTIOUS DISEASES IN ANIMALS
5.4.3 EXPANSIVE GROWTH IN VETERINARY BUSINESSES
5.5 VALUE CHAIN ANALYSIS
FIGURE 28 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM MARKET MAP
FIGURE 29 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS
FIGURE 30 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:
ECOSYSTEM MARKET
5.7 PORTER’S FIVE FORCES ANALYSIS
TABLE 10 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 THREAT OF SUBSTITUTES
5.7.3 BARGAINING POWER OF SUPPLIERS
5.7.4 BARGAINING POWER OF BUYERS
5.7.5 INTENSITY OF COMPETITIVE RIVALRY
5.8 PRICING ANALYSIS
TABLE 11 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2021 (USD)
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS
5.9.2 PATENT PUBLICATION TRENDS (2011–DECEMBER 2021)
5.9.3 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PATENTS (JANUARY
2011–DECEMBER 2021)
FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2011–DECEMBER 2021)
5.10 TECHNOLOGICAL ANALYSIS
5.10.1 KEY TECHNOLOGY
5.10.1.1 Development of portable instruments for POC diagnostic services
TABLE 12 PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS
5.10.2 ADJACENT TECHNOLOGY
5.10.2.1 Development of rapid and sensitive veterinary diagnostic kits
6 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
TABLE 13 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
6.2 IMMUNODIAGNOSTICS
TABLE 14 KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN THE MARKET
TABLE 15 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 16 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1 LATERAL FLOW ASSAYS
6.2.1.1 Lateral flow assays offer rapid results & accurate diagnosis
TABLE 17 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2 ELISA TESTS
6.2.2.1 ELISA tests have gained widespread popularity in the market owing to their efficacy and accurate validation of results
TABLE 18 ELISA TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3 OTHER IMMUNODIAGNOSTIC PRODUCTS
TABLE 19 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3 MOLECULAR DIAGNOSTICS
TABLE 20 KEY VETERINARY MOLECULAR DIAGNOSTICS PRODUCTS
AVAILABLE IN THE MARKET
TABLE 21 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 22 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.1 POLYMERASE CHAIN REACTION (PCR) TESTS
6.3.1.1 PCR is an effective tool for the diagnosis of diseases in food-producing animals and companion animals
TABLE 23 PCR TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.2 MICROARRAYS
6.3.2.1 Technological advancements and the increasing incidence of infectious diseases are factors supporting the growth of this market
TABLE 24 MICROARRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
TABLE 25 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.4 OTHER TECHNOLOGIES
TABLE 26 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION)
7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE
7.1 INTRODUCTION
TABLE 27 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
7.2 COMPANION ANIMALS
TABLE 28 POPULATION OF COMPANION ANIMALS, BY COUNTRY, 2012–2019 (MILLION)
TABLE 29 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 30 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.1 DOGS
7.2.1.1 The pet dog population has grown significantly in recent years
TABLE 31 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING DOGS
TABLE 32 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING DOGS
TABLE 33 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 CATS
7.2.2.1 Increasing pet cat population to drive the market growth
TABLE 34 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATS
TABLE 35 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATS
TABLE 36 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 HORSES
7.2.3.1 Research programs on horse health awareness is a major factor driving the demand for infection diagnostics for this segment
TABLE 37 HORSE POPULATION, BY REGION, 2014–2017 (USD MILLION)
TABLE 38 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING HORSES
TABLE 39 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING HORSES
TABLE 40 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 OTHER COMPANION ANIMALS
TABLE 41 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE
TABLE 42 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
7.2.5.1 Viral infections
7.2.5.1.1 The highly contagious nature of viral diseases is a major factor driving the demand for infection diagnostics in companion animals
TABLE 43 PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN COMPANION ANIMALS
TABLE 44 VIRAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.2.5.2 Bacterial infections
7.2.5.2.1 The bacterial infections segment accounted for the largest share of the market in 2020
TABLE 45 PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN COMPANION ANIMALS
TABLE 46 BACTERIAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.2.5.3 Parasitic infections
7.2.5.3.1 Rising incidence of worm infestation in companion animals to support the growth of this market
TABLE 47 PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS IN COMPANION ANIMALS
TABLE 48 PARASITIC DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.2.5.4 Other infections
TABLE 49 PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN COMPANION ANIMALS
TABLE 50 PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS IN COMPANION ANIMALS
TABLE 51 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3 FOOD-PRODUCING ANIMALS
7.3.1 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE
TABLE 52 POPULATION OF FOOD-PRODUCING ANIMALS IN THE US, 2012 TO 2019 (MILLION)
TABLE 53 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 54 INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.1 Cattle
7.3.1.1.1 Growing demand for meat & dairy products to support the growth of this segment
TABLE 55 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATTLE
TABLE 56 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATTLE
TABLE 57 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.2 Swine
7.3.1.2.1 Extensive use of infectious disease diagnostics as a response to epidemic outbreaks in this segment
TABLE 58 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING SWINE
TABLE 59 SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING SWINE
TABLE 60 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR SWINE, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.3 Poultry
7.3.1.3.1 The growth of this segment is driven by the growing poultry population and rising production volumes
TABLE 61 SOME OF THE IMPORTANT ZOONOTIC DISEASES AFFECTING POULTRY
TABLE 62 SOME IMPORTANT INFECTIOUS DISEASES AFFECTING POULTRY
TABLE 63 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.1.4 Other food-producing animals
TABLE 64 SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING OTHER FOOD -PRODUCING ANIMALS
TABLE 65 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3.2 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE
TABLE 66 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
7.3.2.1 Bacterial infections
7.3.2.1.1 The bacterial infections segment accounted for the largest share of the food-producing animals market in 2020
TABLE 67 PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN FOOD-PRODUCING ANIMALS
TABLE 68 BACTERIAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3.2.2 Viral infections
7.3.2.2.1 Need for early disease diagnosis and the rising awareness for viral infections to support the market growth
TABLE 69 PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN FOOD-PRODUCING ANIMALS
TABLE 70 VIRAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3.2.3 Parasitic infections
7.3.2.3.1 Worm infestations are a significant problem for pet & companion animal owners
TABLE 71 PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS
IN FOOD-PRODUCING ANIMALS
TABLE 72 PARASITIC DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
7.3.2.4 Other infections
TABLE 73 PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN FOOD-PRODUCING ANIMALS
TABLE 74 PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS
IN FOOD- PRODUCING ANIMALS
TABLE 75 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)
8 VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER
8.1 INTRODUCTION
TABLE 76 VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 VETERINARY REFERENCE LABORATORIES
8.2.1 VETERINARY REFERENCE LABORATORIES IS THE LARGEST
END USER SEGMENT
TABLE 77 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 VETERINARY HOSPITALS & CLINICS
8.3.1 INCREASED PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET GROWTH
FIGURE 33 US: PET INDUSTRY EXPENDITURE
FIGURE 34 ANNUAL ROUTINE VETERINARY VISIT EXPENDITURE: DOGS AND CATS
TABLE 78 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 POINT-OF-CARE/ IN-HOUSE TESTING
8.4.1 POINT-OF-CARE TESTING IS EASY-TO-USE, COST-EFFECTIVE, AND OFFERS SWIFT RESULTS
TABLE 79 KEY PRODUCTS OFFERED BY MARKET PLAYERS
TABLE 80 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POINT-OF-CARE/ IN-HOUSE TESTING, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
8.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES & UNIVERSITIES TO DRIVE MARKET GROWTH
TABLE 81 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2019–2026 (USD MILLION)
9 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 82 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 35 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA
FIGURE 36 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
TABLE 83 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 84 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 85 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 86 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 87 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 88 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 90 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 92 NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominated the North American veterinary infectious disease diagnostics market in 2020
FIGURE 37 US: DOGS POPULATION, 2012–2020 (MILLION)
FIGURE 38 US: EXPENDITURE ON VET VISITS
TABLE 93 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION)
FIGURE 39 US: NUMBER OF CATS AND DOGS TESTED POSITIVE FOR COVID-19 (2020)
TABLE 94 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014–2019
TABLE 95 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 96 US: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 97 US: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 98 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 99 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 101 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 103 US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing pet adoption in Canada to drive the market growth
FIGURE 40 CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION)
TABLE 104 CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
TABLE 105 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 106 CANADA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 107 CANADA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 108 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 109 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 111 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 113 CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 114 EUROPE: COMPANION POPULATION, 2019 (MILLION)
TABLE 115 EUROPE: LIVESTOCK POPULATION, 2019 (MILLION)
FIGURE 41 EU-27: LIVESTOCK POPULATION, 2012-2019 (MILLION)
TABLE 116 EUROPE: NUMBER OF VETERINARIANS, 2012–2019
TABLE 117 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 118 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 119 EUROPE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 120 EUROPE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 121 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 122 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 124 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 126 EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Rising awareness regarding zoonotic diseases to drive the market growth in Germany
TABLE 127 GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 128 GERMANY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 129 GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019
TABLE 130 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 131 GERMANY: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 132 GERMANY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 133 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 134 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 136 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 138 GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 The UK is the fastest-growing market for veterinary infectious disease diagnostics in Europe
TABLE 139 UK: COMPANION ANIMAL POPULATION (2010–2019) (MILLION)
TABLE 140 UK: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 141 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 142 UK: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 143 UK: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 144 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 145 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 146 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 147 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 149 UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 France is one of the leading markets for companion pet ownership
TABLE 150 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION)
TABLE 151 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 152 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 153 FRANCE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 154 FRANCE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 155 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 156 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 157 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 158 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 159 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 160 FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Rising awareness about pet healthcare to propel the market growth for veterinary diagnostic products in Italy
TABLE 161 ITALY: COMPANION ANIMAL POPULATION, 2012–2019 (MILLION)
TABLE 162 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 163 ITALY: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 164 ITALY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 165 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 166 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 167 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 168 ITALY: VETERINARY DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 170 ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing demand for pig & poultry products to support the adoption of veterinary diagnostic products in Spain
TABLE 171 SPAIN: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 172 SPAIN: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 173 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 174 SPAIN: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 175 SPAIN: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 176 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 177 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 178 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 179 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 180 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 181 SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 182 ROE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2019 (MILLION)
TABLE 183 ROE: LIVESTOCK ANIMAL POPULATION, BY COUNTRY, 2019 (MILLION)
TABLE 184 ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2019
TABLE 185 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 186 ROE: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 187 ROE: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 188 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 189 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 190 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 191 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 192 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 193 ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 42 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT
TABLE 194 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 195 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 196 ASIA PACIFIC: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 197 ASIA PACIFIC: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 198 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 199 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 200 ASIA PACIFIC: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 201 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 202 ASIA PACIFIC: FOOD-PRODUCING ANIMALS ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 203 ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China dominated the APAC veterinary infectious disease diagnostic market in 2020
TABLE 204 CHINA: LIVESTOCK POPULATION, 2010-2019 (MILLION)
TABLE 205 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 206 CHINA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 207 CHINA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 208 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 209 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 210 CHINA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 211 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 212 CHINA: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 213 CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising awareness about zoonotic diseases and increasing pet expenditure to drive market growth
TABLE 214 JAPAN: PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 215 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 216 JAPAN: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 217 JAPAN: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 218 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 219 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 220 JAPAN: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 221 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 222 JAPAN: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 223 JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 India to become an untapped market with huge growth potential
TABLE 224 INDIA: LIVESTOCK POPULATION, 2007-2019 (MILLION)
TABLE 225 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 226 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 227 INDIA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 228 INDIA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 229 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 230 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 231 INDIA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 232 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 233 INDIA: FOOD- PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 234 INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 REST OF APAC
TABLE 235 REST OF APAC: LIVESTOCK POPULATION, BY COUNTRY, 2010-2019 (MILLION)
TABLE 236 ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 237 ROAPAC: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 238 ROAPAC: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 239 ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 240 ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 241 ROAPAC: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 242 ROPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 243 ROPAC: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 244 ROPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 245 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY, 2010-2019 (MILLION)
TABLE 246 LATIN AMERICA: NUMBER OF VETERINARIANS AND PARA VETERINARIANS, 2010 VS. 2019
TABLE 247 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 248 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 249 LATIN AMERICA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 250 LATIN AMERICA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 251 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 252 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 253 LATIN AMERICA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 254 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 255 LATIN AMERICA: FOOD-PRODUICNG ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 256 LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil has the fourth-largest pet population in the world
TABLE 257 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 258 BRAZIL: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 259 BRAZIL: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 260 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 261 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 262 BRAZIL: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 263 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 264 BRAZIL: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 265 BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Mexico is the second-largest pet care market in Latin America
TABLE 266 MEXICO: INCREASE IN LIVESTOCK POPULATION, 2010–2019 (MILLION)
TABLE 267 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 268 MEXICO: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 269 MEXICO: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 270 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 271 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 272 MEXICO: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 273 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 274 MEXICO: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 275 MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 276 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 277 ROLA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 278 ROLA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 279 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 280 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 281 ROLA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 282 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 283 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 284 ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 MIDDLE EAST & AFRICA IS AN EMERGING MARKET FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PRODUCTS
TABLE 285 MIDDLE EAST: LIVESTOCK POPULATION, 2010 VS. 2019 (MILLION)
TABLE 286 MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2018
TABLE 287 AFRICA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION)
TABLE 288 AFRICA: NUMBER OF VETERINARIANS AND PARA VETERINARIANS, 2010–2018
TABLE 289 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 290 MEA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 291 MEA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 292 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)
TABLE 293 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 294 MEA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 295 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 296 MEA: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)
TABLE 297 MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/ RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 43 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 44 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2020
TABLE 298 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEGREE
OF COMPETITION
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 45 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 46 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2020)
10.7 COMPANY FOOTPRINT
TABLE 299 COMPANY FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
10.7.1 TECHNOLOGY FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
TABLE 300 TECHNOLOGY FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)
10.7.2 ANIMAL FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
TABLE 301 ANIMAL TYPE FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)
10.7.3 END-USER FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
TABLE 302 END-USER FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)
10.7.4 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET
TABLE 303 GEOGRAPHIC FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 304 PRODUCT LAUNCHES, 2018–2021
10.8.2 DEALS
TABLE 305 DEALS, 2018–2021
10.8.3 OTHER DEVELOPMENTS
TABLE 306 OTHER DEVELOPMENTS, 2018–2021
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 IDEXX LABORATORIES, INC.
TABLE 307 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 47 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.2 ZEOTIS
TABLE 308 ZOETIS: BUSINESS OVERVIEW
FIGURE 48 ZOETIS: COMPANY SNAPSHOT (2020)
11.1.3 THERMO FISHER SCIENTIFIC INC.
TABLE 309 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
11.1.4 VIRBAC
TABLE 310 VIRBAC: BUSINESS OVERVIEW
FIGURE 50 VIRBAC: COMPANY SNAPSHOT (2020)
11.1.5 BIOMERIEUX S.A.
TABLE 311 BIOMERIEUX S.A.: BUSINESS OVERVIEW
FIGURE 51 BIOMERIEUX S.A.: COMPANY SNAPSHOT (2020)
11.1.6 HESKA CORPORATION
TABLE 312 HESKA CORPORATION: BUSINESS OVERVIEW
FIGURE 52 HESKA CORPORATION: COMPANY SNAPSHOT (2020)
11.1.7 IDVET
TABLE 313 IDVET: BUSINESS OVERVIEW
11.1.8 NEOGEN CORPORATION
TABLE 314 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 53 NEOGEN CORPORATION: COMPANY SNAPSHOT (2020)
11.1.9 QIAGEN N.V. (A PART OF INDICAL BIOSCIENCE)
TABLE 315 QIAGEN N.V.: BUSINESS OVERVIEW
FIGURE 54 QIAGEN N.V.: COMPANY SNAPSHOT (2020)
11.1.10 RANDOX LABORATORIES LTD.
TABLE 316 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
11.1.11 AGROLABO S.P.A.
TABLE 317 AGROLABO S.P.A.: BUSINESS OVERVIEW
11.1.12 BIONOTE USA INC.
TABLE 318 BIONOTE USA INC.: BUSINESS OVERVIEW
11.1.13 BIOGAL GALED LABS
TABLE 319 BIOGAL GALED LABS: BUSINESS OVERVIEW
11.1.14 BIOCHEK
TABLE 320 BIOCHEK: BUSINESS OVERVIEW
11.1.15 BIOPANDA REAGENTS LTD.
TABLE 321 BIOPANDA REAGENTS LTD.: BUSINESS OVERVIEW
11.1.16 URIT MEDICAL ELECTRONIC CO., LTD.
TABLE 322 URIT MEDICAL ELECTRONIC CO., LTD.: BUSINESS OVERVIEW
11.1.17 MEGACOR DIAGNOSTIK GMBH
TABLE 323 MEGACOR DIAGNOSTIK GMBH: BUSINESS OVERVIEW
11.1.18 BIO-RAD LABORATORIES, INC.
TABLE 324 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
FIGURE 55 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.19 LIVET
TABLE 325 LIVET: BUSINESS OVERVIEW
11.1.20 INDICAL BIOSCIENCE GMBH
TABLE 326 INDICAL BIOSCIENCE GMBH: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 FASSISI, GMBH
11.2.2 ALVEDIA
11.2.3 SKYER, INC.
11.2.4 SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.
11.2.5 PRECISION BIOSENSOR
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
